OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
3154$831.0058

Medius Holdings Co Ltd

Medical Equipment, Supplies & DistributionVerified

Medius Holdings Co Ltd has a liquidity position that is characterized by a current ratio of 1.09 and a debt-to-equity ratio of 1.07, indicating a moderate level of leverage. The company's liquidity is further reflected in its cash and equivalents of 14,333,767,000 JPY, which is partially offset by long-term debt of 21,889,198,000 JPY, resulting in a net cash position that is negative. The company's profitability is modest, with a return on equity of 6.72% and a return on assets of 1.22%. These figures are below the industry norms for medical equipment and supplies distribution, suggesting that the company may not be as efficient in generating returns from its equity and assets as its peers. In terms of segments and geographic exposure, Medius Holdings Co Ltd operates through two business segments: Medical Equipment Sales and Care and Welfare. The company's revenue is concentrated in Japan, with the majority of its sales and rental activities directed towards domestic hospitals and individuals. This concentration may expose the company to regional economic fluctuations and regulatory changes. The growth trajectory of Medius Holdings Co Ltd is not explicitly detailed in the provided data, but the company's recent financial performance suggests a stable, if not particularly dynamic, growth pattern. The company's operating income and net income have shown a consistent, albeit modest, increase, which may indicate a steady, if not aggressive, growth strategy. The risk assessment for Medius Holdings Co Ltd indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. The dilution risk is considered low, which is supported by the company's current share structure and the absence of significant dilution sources. Recent events related to Medius Holdings Co Ltd include the latest actual EPS of 61.92 JPY and the latest actual revenue of 288,689,340,000 JPY. These figures reflect the company's recent financial performance and may be indicative of its operational efficiency and market position.

30-day price · 3154-13.00 (-1.5%)
Low$811.00High$858.00Close$845.00As of21 May, 00:00 UTC
Profile
CompanyMedius Holdings Co Ltd
Ticker3154.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Medius Holdings Co Ltd operates in the medical equipment and nursing care equipment sales and rental market, primarily serving hospitals and individuals in Japan.

Classification. The company is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

Medius Holdings Co Ltd has a liquidity position that is characterized by a current ratio of 1.09 and a debt-to-equity ratio of 1.07, indicating a moderate level of leverage. The company's liquidity is further reflected in its cash and equivalents of 14,333,767,000 JPY, which is partially offset by long-term debt of 21,889,198,000 JPY, resulting in a net cash position that is negative. The company's profitability is modest, with a return on equity of 6.72% and a return on assets of 1.22%. These figures are below the industry norms for medical equipment and supplies distribution, suggesting that the company may not be as efficient in generating returns from its equity and assets as its peers. In terms of segments and geographic exposure, Medius Holdings Co Ltd operates through two business segments: Medical Equipment Sales and Care and Welfare. The company's revenue is concentrated in Japan, with the majority of its sales and rental activities directed towards domestic hospitals and individuals. This concentration may expose the company to regional economic fluctuations and regulatory changes. The growth trajectory of Medius Holdings Co Ltd is not explicitly detailed in the provided data, but the company's recent financial performance suggests a stable, if not particularly dynamic, growth pattern. The company's operating income and net income have shown a consistent, albeit modest, increase, which may indicate a steady, if not aggressive, growth strategy. The risk assessment for Medius Holdings Co Ltd indicates a medium level of liquidity risk and a low level of dilution risk. The company's key financial flags include a negative net cash position after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. The dilution risk is considered low, which is supported by the company's current share structure and the absence of significant dilution sources. Recent events related to Medius Holdings Co Ltd include the latest actual EPS of 61.92 JPY and the latest actual revenue of 288,689,340,000 JPY. These figures reflect the company's recent financial performance and may be indicative of its operational efficiency and market position.
Key takeaways
  • Medius Holdings Co Ltd has a moderate level of leverage with a debt-to-equity ratio of 1.07.
  • The company's profitability is below industry norms, with a return on equity of 6.72%.
  • The company's operations are concentrated in Japan, which may expose it to regional economic and regulatory risks.
  • The company's liquidity position is characterized by a current ratio of 1.09 and a negative net cash position after subtracting total debt.
  • The company's recent financial performance suggests a stable, if not particularly dynamic, growth pattern.
  • --
  • # RATIONALES
  • **margin_outlook_rationale**: The company's gross profit margin is expected to remain stable, driven by consistent sales and maintenance of medical equipment.
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$288.69B
Gross profit$34.44B
Operating income$1.83B
Net income$1.38B
R&D
SG&A
D&A
SBC
Operating cash flow$6.75B
CapEx-$2.07B
Free cash flow$1.05B
Total assets$113.02B
Total liabilities$92.55B
Total equity$20.48B
Cash & equivalents$14.33B
Long-term debt$21.89B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$831.00
Market cap$18.48B
Enterprise value$26.03B
P/E13.4
Reported non-GAAP P/E
EV/Revenue0.1
EV/Op income14.3
EV/OCF3.9
P/B0.9
P/Tangible book0.9
Tangible book$20.48B
Net cash-$7.56B
Current ratio1.1
Debt/Equity1.1
ROA1.2%
ROE6.7%
Cash conversion4.9%
CapEx/Revenue-0.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric3154Activity
Op margin0.6%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin0.5%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin11.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-0.7%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity107.0%69.3% medp25 63.4% · p75 74.5%top quartile
Observations
IR observations
Last actual EPS61.92 JPY
Last actual revenue288,689,340,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:20 UTC#2cb194a9
Market quoteclose JPY 831.00 · shares 0.02B diluted
no public URL
2026-05-10 12:20 UTC#658937ee
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:23 UTCJob: cfc4049f